Cargando…
Molecular and genetic diversity in the metastatic process of melanoma
Diversity between metastatic melanoma tumours in individual patients is known; however, the molecular and genetic differences remain unclear. To examine the molecular and genetic differences between metastatic tumours, we performed gene-expression profiling of 63 melanoma tumours obtained from 28 pa...
Autores principales: | Harbst, Katja, Lauss, Martin, Cirenajwis, Helena, Winter, Christof, Howlin, Jillian, Törngren, Therese, Kvist, Anders, Nodin, Björn, Olsson, Eleonor, Häkkinen, Jari, Jirström, Karin, Staaf, Johan, Lundgren, Lotta, Olsson, Håkan, Ingvar, Christian, Gruvberger-Saal, Sofia K, Saal, Lao H, Jönsson, Göran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359751/ https://www.ncbi.nlm.nih.gov/pubmed/24399611 http://dx.doi.org/10.1002/path.4318 |
Ejemplares similares
-
NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics
por: Cirenajwis, Helena, et al.
Publicado: (2017) -
Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
por: Cirenajwis, Helena, et al.
Publicado: (2015) -
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours
por: Howlin, Jillian, et al.
Publicado: (2015) -
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer
por: Olsson, Eleonor, et al.
Publicado: (2015) -
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer
por: Dahlgren, Malin, et al.
Publicado: (2023)